Source: PR Newswire

Press Release: Theravance Biopharma : Theravance Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025

/PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its first quarter 2025 financial results and provide a business update after market close...

Read full article »
Theravance Biopharma's Competitors | Theravance Biopharma's News | Theravance Biopharma's Financials
Stay up-to-date with the latest news on Theravance Biopharma
Annual Revenue
$25-100M
Employees
25-100
Rick E. Winningham's photo - Chairman & CEO of Theravance Biopharma

Chairman & CEO

Rick E. Winningham

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Theravance Biopharma